Processa Pharmaceuticals, Inc. (ticker: PCSA) is an NASDAQ-listed pharmaceutical preparations company. DredgeCap's structured extraction of PCSA's SEC filings surfaces 9 active risk signals, including 8 late-filing signals, and 1 auditor-change signal. PCSA reported $0 in revenue and -$3.38M for the period ending 2023-09-30, with operating cash flow of -$3.59M. Cash and equivalents stood at $1.69M (down 41.6% year-over-year). Total assets of $4.52M exceed total liabilities of $1.98M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
PCSA SEC Filings
Full cached SEC EDGAR filing history for PCSA, grouped by form type and sorted newest-first within each group. 0 filings across 0 form types.
Filings sourced verbatim from SEC EDGAR submissions metadata. “Structured” links route to DredgeCap's per-filing renderer (XBRL-backed financials + cited highlights) when available; the EDGAR link always points to the canonical accession index on sec.gov.